Cargando…

Albumin losses during hemodiafiltration: all dialyzers are not created equal - a case report

BACKGROUND: Online hemodiafiltration (OL-HDF) is associated with better removal of both small and middle molecules and might improve survival compared to conventional hemodialysis (HD). Nevertheless, hemodiafiltration (HDF) can lead to an increase in albumin loss across the dialyzer, especially with...

Descripción completa

Detalles Bibliográficos
Autores principales: Cuvelier, Charles, Tintillier, Michel, Migali, Gabriela, Van Ende, Charlotte, Pochet, Jean-Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819538/
https://www.ncbi.nlm.nih.gov/pubmed/31660886
http://dx.doi.org/10.1186/s12882-019-1567-8
_version_ 1783463754757832704
author Cuvelier, Charles
Tintillier, Michel
Migali, Gabriela
Van Ende, Charlotte
Pochet, Jean-Michel
author_facet Cuvelier, Charles
Tintillier, Michel
Migali, Gabriela
Van Ende, Charlotte
Pochet, Jean-Michel
author_sort Cuvelier, Charles
collection PubMed
description BACKGROUND: Online hemodiafiltration (OL-HDF) is associated with better removal of both small and middle molecules and might improve survival compared to conventional hemodialysis (HD). Nevertheless, hemodiafiltration (HDF) can lead to an increase in albumin loss across the dialyzer, especially with high permeability membrane and high convective volume (CV). We present the case of a patient treated by OL-HDF who developed severe hypoalbuminemia resulting from massive albumin loss into dialysate. CASE PRESENTATION: A 71-year-old woman with ESRD started renal replacement therapy in December 2016. She was treated by high volume post-dilution OL-HDF, 4 h, 3 times per week. The dialyzer was the Phylther HF20SD (a 2.0m(2) heat sterilized high flux (HF) polyphenylene membrane from Bellco). At the initiation of dialysis, the serum albumin was 4.0 g/dl. During the following months, the patient developed severe hypoalbuminemia. The lowest value observed was 2.26 g/dl in July 2017. Diagnostic workup excluded nephrotic syndrome, hepatic failure and malabsorption. The patient was shifted from OL-HDF to standard HF HD, keeping the same dialyzer and dialysis schedule. During the following months, we observed a progressive correction of the hypoalbuminemia (3.82 g/dl at last follow-up). To precise the impact of the epuration technique on the albumin losses in this patient, we measured the amount of albumin in dialysate during one session with the Phylther HF20SD on OL-HDF and one session with the same filter but on standard HD. The CV was 29.0 l for the HDF session. The total albumin losses were 23.6 g on OL-HDF and 4.6 g on HD. CONCLUSION: OL-HDF can lead to significant albumin loss into the dialysate, especially with high permeability membrane and high CV. When prescribing post-dilutional OL-HDF, the choice of the dialyzer membrane should be made with caution. Users of the steam sterilized polyphenylene membrane, the Phylther SD, should be informed of the risk of large albumin loss with this membrane during post-dilution OL-HDF.
format Online
Article
Text
id pubmed-6819538
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-68195382019-10-31 Albumin losses during hemodiafiltration: all dialyzers are not created equal - a case report Cuvelier, Charles Tintillier, Michel Migali, Gabriela Van Ende, Charlotte Pochet, Jean-Michel BMC Nephrol Case Report BACKGROUND: Online hemodiafiltration (OL-HDF) is associated with better removal of both small and middle molecules and might improve survival compared to conventional hemodialysis (HD). Nevertheless, hemodiafiltration (HDF) can lead to an increase in albumin loss across the dialyzer, especially with high permeability membrane and high convective volume (CV). We present the case of a patient treated by OL-HDF who developed severe hypoalbuminemia resulting from massive albumin loss into dialysate. CASE PRESENTATION: A 71-year-old woman with ESRD started renal replacement therapy in December 2016. She was treated by high volume post-dilution OL-HDF, 4 h, 3 times per week. The dialyzer was the Phylther HF20SD (a 2.0m(2) heat sterilized high flux (HF) polyphenylene membrane from Bellco). At the initiation of dialysis, the serum albumin was 4.0 g/dl. During the following months, the patient developed severe hypoalbuminemia. The lowest value observed was 2.26 g/dl in July 2017. Diagnostic workup excluded nephrotic syndrome, hepatic failure and malabsorption. The patient was shifted from OL-HDF to standard HF HD, keeping the same dialyzer and dialysis schedule. During the following months, we observed a progressive correction of the hypoalbuminemia (3.82 g/dl at last follow-up). To precise the impact of the epuration technique on the albumin losses in this patient, we measured the amount of albumin in dialysate during one session with the Phylther HF20SD on OL-HDF and one session with the same filter but on standard HD. The CV was 29.0 l for the HDF session. The total albumin losses were 23.6 g on OL-HDF and 4.6 g on HD. CONCLUSION: OL-HDF can lead to significant albumin loss into the dialysate, especially with high permeability membrane and high CV. When prescribing post-dilutional OL-HDF, the choice of the dialyzer membrane should be made with caution. Users of the steam sterilized polyphenylene membrane, the Phylther SD, should be informed of the risk of large albumin loss with this membrane during post-dilution OL-HDF. BioMed Central 2019-10-28 /pmc/articles/PMC6819538/ /pubmed/31660886 http://dx.doi.org/10.1186/s12882-019-1567-8 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Case Report
Cuvelier, Charles
Tintillier, Michel
Migali, Gabriela
Van Ende, Charlotte
Pochet, Jean-Michel
Albumin losses during hemodiafiltration: all dialyzers are not created equal - a case report
title Albumin losses during hemodiafiltration: all dialyzers are not created equal - a case report
title_full Albumin losses during hemodiafiltration: all dialyzers are not created equal - a case report
title_fullStr Albumin losses during hemodiafiltration: all dialyzers are not created equal - a case report
title_full_unstemmed Albumin losses during hemodiafiltration: all dialyzers are not created equal - a case report
title_short Albumin losses during hemodiafiltration: all dialyzers are not created equal - a case report
title_sort albumin losses during hemodiafiltration: all dialyzers are not created equal - a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819538/
https://www.ncbi.nlm.nih.gov/pubmed/31660886
http://dx.doi.org/10.1186/s12882-019-1567-8
work_keys_str_mv AT cuveliercharles albuminlossesduringhemodiafiltrationalldialyzersarenotcreatedequalacasereport
AT tintilliermichel albuminlossesduringhemodiafiltrationalldialyzersarenotcreatedequalacasereport
AT migaligabriela albuminlossesduringhemodiafiltrationalldialyzersarenotcreatedequalacasereport
AT vanendecharlotte albuminlossesduringhemodiafiltrationalldialyzersarenotcreatedequalacasereport
AT pochetjeanmichel albuminlossesduringhemodiafiltrationalldialyzersarenotcreatedequalacasereport